Influx Healthtech Profit & Loss Annual

BSE: - | NSE: INFLUX | ISIN: INE0MYZ01012 | Sector: Biotechnology & Drugs

285.00 -6.75 (-2.31%)Updated : 07 Aug 2026

Research on

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	120.75	87.01	84.83	66.26
Other Net	1.33	0.00	-0.05	-0.05
Diluted Weighted Average Shares	2.20	1.82	2.32	2.32
Depreciation/ Amortization	3.78	2.82	1.85	0.94
Operating Income	26.08	17.85	15.13	9.80
Net Income	20.54	13.27	11.22	7.20
Income Availableto Com Excl Extra Ord	20.54	13.27	11.22	7.20
Net Income Before Taxes	27.23	17.71	15.10	9.74
Other Operating Expenses Total	18.53	9.74	9.80	6.76
Net Income After Taxes	20.54	13.27	11.22	7.20
Income Availableto Com Incl Extra Ord	20.54	13.27	11.22	7.20
Costof Revenue Total	86.69	64.66	65.86	53.36
Gross Profit	60.14	40.20	34.11	22.69
Interest Inc( Exp) Net- Non- Op Total	-0.18	-0.13	0.02	-0.01
Diluted Net Income	20.54	13.27	11.22	7.20
Provisionfor Income Taxes	6.69	4.44	3.88	2.54
period Type	-	-	-	-
Net Income Before Extra Items	20.54	13.27	11.22	7.20
Total Revenue	146.83	104.85	99.97	76.06
period Length	12.00	12.00	12.00	12.00
Revenue	146.83	104.85	99.97	76.06
Selling/ General/ Admin Expenses Total	11.75	9.78	7.32	5.20
Diluted Normalized EPS	9.35	7.31	4.85	3.11
Diluted EPS Excluding Extra Ord Items	9.35	7.31	4.85	3.11

*All figures in crores except per share values

Trending Stocks

2,427.00+57.00(2.41%)

1,653.95+18.95(1.16%)

3,443.60+28.60(0.84%)

1,093.40-56.50 (-4.91%)

2,007.00-82.25 (-3.94%)

Related News